Melanoma
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...
Latest News
USPSTF releases updated recommendations on skin cancer screening
“Our recommendations are for patients who present to primary care without symptoms, and after a careful assessment of benefit and harms, we didn’t...
Conference Coverage
Pembrolizumab monotherapy effective for rare melanoma
Patients with unresectable desmoplastic melanoma experienced a response rate that was nearly double other melanomas.
Latest News
Study highlights potential skin cancer risk of UV nail polish dryers
Often referred to as ‘mini tanning beds,’ UV nail polish dryers emit UVA radiation, classified as a carcinogen by the International Agency for...
News
Survival improved for some patients with metastatic cancers
Among patients with metastatic gastrointestinal stromal tumors, neuroendocrine tumors, melanoma, and several cancers, 5-year survival increased by...
News
Increased cancer in military pilots and ground crew: Pentagon
But military aircrew and ground crew were less likely to die from cancer, compared with the U.S. population.
Latest News
Melanoma screening: Consensus statement offers greater clarity
Overall, the panelists agreed that a risk-stratified approach is likely the most appropriate strategy for melanoma screening and follow-up and...
Article
Dermatologic Implications of Sleep Deprivation in the US Military
In this article, we explore possible mechanisms by which sleep deprivation may affect the skin. We also review the potential impacts of sleep...
Latest News
Pembrolizumab before and after melanoma surgery boosts outcomes
"It's not just what you give; it's when you give it," said lead author Sapna Patel, MD, in a press release.